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The fluctuation of physiological pH from homeostatic levels has the potential to cause life threatening
complications unless counteracted in a timely manner. Therefore, the development of reliable and ac-
curate sensors for the continuous monitoring of pH is of vital importance for clinical monitoring. Herein,
we describe the extensive in vitro characterisation of a quinone-modified carbon paste electrode (CPE)
and its subsequent in vivo validation in the peripheral tissue of anaesthetised rats. Sensocompatibility
investigations identified stable and accurate measurements in lipid (phosphatidylethanolamine; PEA)
and protein (bovine serum albumin; BSA) solutions when the pH sensor was continuously cycled for nine
hours in the physiological contaminants. The influence of endogenous electroactive molecules e.g.,
ascorbic acid and uric acid and pharmacological interferents e.g., acetaminophen and acetylsalicylic acid
was deemed negligible on the pH sensitive peak. Furthermore, there was no impact of ionic strength and
the quinone oxidation peak remained selective for Hþ over other endogenous cations. The effect of
temperature and a pseudo reference electrode (PRE) on the sensor performance have also been eluci-
dated. The efficacy of the modified-CPE to respond to in vivo tissue pH dynamics was demonstrated using
a model of peripheral ischaemia and sodium bicarbonate injections. Collectively, this body of evidence
clearly support the ability of the quinone-modified CPE to continuously measure pH fluctuations under
physiological conditions.
© 2018 Elsevier Ltd. All rights reserved.1. Introduction
Real-time monitoring of physiological pH levels is important for
many reasons. For example, abnormal tissue pH is an indicator of
altered cellular metabolism in diseases including stroke [1] and
cancer [2]. In particular, tissue ischaemic injury, i.e. reduced blood
flow, is one of the most common types of injury in clinical medicine
[3e5]. Ischaemic tissue is generally caused by obstruction of an
artery. The affected tissue often becomes acidic due to increased
anaerobic respiration leading to irreversible cellular damage. The
first investigations into the relationship between pH levels and
ischaemia were reported nearly 35e40 years ago, identifying that
tissue pH falls during an ischaemic event [6e8]. Researchers agreed
that tissue pH fell as the decrease in blood flow to the tissue
resulted in anaerobic metabolism, which consequently produced
lactate. The presence of lactate contributes to an increase in Hþ ion
activity, which is proportional to a decrease in pH. Thus, pH can be).used as an indication of a reduction of tissue perfusion [6,7,9].
In-vivo sensors can provide an instant evaluation of a biological
parameter such as tissue pH [10]. For this purpose, small devices
with low drift, easy calibration, immunity to electrode fouling and
long life-time are required. Wolpert et al. compared serum pH
measurements to that of tissue pH [7]. They found that tissue pH,
when compared to serum pH, had the advantages of reacting earlier
to changes in tissue perfusion and it could be measured with
minimal invasiveness. These studies involvedminiaturised glass pH
sensors, whose major disadvantages lie in the difficulty of minia-
turisation [11], drift [12], fragility [13] and electrode fouling [14],
culminating in inaccuratemeasurements. Voltammetric pH sensors
have recently demonstrated excellent potential both in vitro
[15e17] and in vivo [18,19]. They function by measuring the redox
potential of a pH dependent moiety, as described by the Nernst
equation.
E ¼ E0 þ ðRT=FÞ ln ½aHþ (1)
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where E is the measured potential, E0 is the standard electrode
potential, R is the universal gas constant, T is the temperature in
Kelvin and F is the Faraday constant.
When characterising a voltammetric pH sensor capable of
continuous in-vivo measurements, certain criteria should be
maintained. The sensor should be easily miniaturised in order to
inflict minimal trauma to the insertion site, thereby reducing the
risk of infection to the subject. Also, the pH response should remain
stable, with minimal drift, over a constant recording period. In
addition, it should demonstrate a fast response time and be inde-
pendent of temperature, cation and ionic strength fluctuations.
Minor changes in pH can be detrimental in vivo, meaning the
sensitivity should be linear over a physiologically relevant range. In
healthy patients, the pH of the blood varies between 7.35 and 7.45;
anything outside 6.8 and 7.8 may result in irreversible cell damage
and eventual death [20e23]. The voltammetric response of an
in vivo sensor should not be compromised by the presence of
electrochemically active moieties found ubiquitously throughout
tissue. It is pivotal to device functionality that selectivity towards
the target species is retained in such a scenario. Physiologically
relevant metal ions can be detrimental to the voltammetric signal,
e.g., Ca2þ and Mg2þ and their impact on sensor performance must
be elucidated.
Biofouling of implanted electrochemical sensors occurs imme-
diately upon contact with living tissue, through physiological re-
sponses from endogenous protein and lipid adsorption. This can
limit the mass transport rate at the electrode surface [24], thereby
affecting the voltammetric signal produced by functionalised CPEs.
The lipophilic nature of biological tissue has been reported to
remove the hydrophobic oil from the CPE [25], thus altering and
potentially compromising the modified surface. Such consider-
ations are one of the major hurdles that need addressing during the
characterisation of an in vivo sensor. In addition to protein and lipid
fouling, the physiological environment is populated with a myriad
of endogenous electroactive interferents. It is therefore pivotal for
the successful characterisation of a voltammetric pH sensor in vivo
that peak resolution is maintained in the presence of such inter-
ferents. Furthermore, changes in ionic strength give rise to changes
in the conductivity of a solution. For example, decreasing the ionic
strength of a solution decreases the conductivity, hence increasing
the solution resistance. This results in an increased IR drop causing
a subsequent potential increase which modifies the observed po-
tential and may impact on voltammetric potential.
Herein, we describe the in vitro characterisation of a recently
reported pH sensitive carbon paste electrode (CPE) [26]. The elec-
trodeposition of the diazonium salt, 4-Benzoylamino-2, 5-
dimethoxybenzenediazonium chloride - hemi zinc chloride
(FBRR), onto CPEs was optimised, to produce a pH sensor that has
demonstrated excellent stability and Nernstian behaviour over the
physiological range 7.2e7.6. Furthermore, increasing the number of
calibration points from three to ca. 40 had no significant impact on
the sensor's sensitivity and shelf-life investigations identified
retention of the FBBR-modified CPE sensitivity over 28 days when
stored under air conditions at 4 C [26]. CPEs have demonstrated
excellent long term stability for in vivo monitoring of brain tissue
[24,27], an environment they are particularly suited to since the
interaction between the pasting liquid and brain lipids reduces the
electrode fouling caused by the proteins [24]. However, the effect
on functionalised CPEs is not well known and the impact on the
covalently bonded pHmoiety was investigated within. The effect of
interferents, cations, ionic strength, temperature and a pseudo
reference electrode (PRE) is also discussed in detail. Finally, thecharacterised sensor was implanted into the hind limb of anaes-
thetised rats and continuous monitoring of tissue pH was per-
formed. Perturbations of tissue pH were undertaken through a
previously described hind limb ischaemia model [28] and local
injections of sodium bicarbonate. During ischaemia, a reduction in
oxygen levels should lead to a concurrent decrease in tissue pH [29]
arising from increasing lactic acid concentrations caused by the
switch to anaerobic metabolism. Conversely, injections of sodium
bicarbonate [30e32], a weak base, were administered locally to the
hind limb of the animals to induce an increase in tissue pH.
Increasing the bicarbonate concentration in the tissue will cause
the acid-base equilibrium to shift to more alkaline, resulting in an
increase in pH.
HCO3 þ Hþ4 CO2 þ H2O (3)
Furthermore, post in vivo calibrations performed on the FBRR-
modified CPE determined no significant difference from pre-
implantation sensitivities. Collectively, the body of work
described within demonstrates the efficacy of the FBRR-modified
CPE at measuring reliable and accurate changes in physiological pH.
2. Materials and methods
2.1. Chemicals and solutions
All reagents used i.e., sodium chloride (NaCl), sodium hydroxide
(NaOH), sodium hydrogen phosphate (NaH2PO4), 4-benzoylamino-
2, 5-dimethoxybenzenediazonium chloride - hemi zinc chloride
(FBRR), graphite powder (<20 mm, 1.9 g/cm3), ilicon oil (0.96 g/mL),
bovine serum albumin (BSA), phosphatidylethanolamine (PEA),
ascorbic acid, L-cysteine, L-gluthathione, L-tyrosine, uric acid, acet-
aminophen, acetylsalicylic acid, dopamine hydrochloride, 3, 4-
dihydroxyphenylacetic acid (DOPAC), 5-hydroxy-indole acetic acid
(5-HIAA), calcium chloride, magnesium chloride were purchased
from Sigma Aldrich Chemical Co. (Dublin, Ireland). Sulfuric acid was
purchased from VWR International Ltd (Dublin, Ireland). Calibra-
tions were performed in phosphate buffered saline (PBS); NaCl
(0.15M), NaOH (0.04M) and NaH2PO4 (0.04M) made up in doubly
distilled deionised water. The pH was adjusted accordingly using a
laboratory pH meter (Eutech Instruments, Ayer Rajah, Singapore).
2.2. Electrode manufacture and preparation
CPEsweremanufactured fromTeflon®-insulated silver (Ag) wire
(200 mm bare diameter 8T, Advent Research Materials; Oxford, UK)
as described previously [26]. A 5 cm length of Teflon insulated Ag
wire was cut. Approximately 1mm of the Teflon® insulation was
removed from one end, exposing the bare Ag wire. Using a twee-
zers, the Teflon® was gently moved along the length of the wire,
exposing a 1mm cavity at the opposite end of the electrode. The
cavity was packed with carbon paste (0.71 g graphite powder
(<20 mm,1.9 g/cm3) and 250 mL silicon oil (0.96 g/mL)). The exposed
Ag wire at the opposite end was soldered into a gold clip (Fine
Science Tools GmbH, Heidelberg, Germany). A bare Ag wire with
the same diameter, was used as a plunger, to ensure that the paste
was compactly packed. The surface was then levelled by gently
rubbing it on a clean, flat surface. The electrochemical deposition of
the quinone containing aryl diazonium salt, FBRR, onto CPEs was
achieved by a one-step electrochemical reduction process in
0.1MH2SO4 using Linear Sweep Voltammetry (LSV) [26]. The first
step of the proposed mechanism involves the electrochemical
reduction of the aryl diazonium cation (Ar-N2þ) to form the corre-
sponding aryl radical (Ar$), with the loss of N2, as described in
Equation (4). The second step occurs when the radical reacts with
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cording to Equation (5):
ArNþ2 þ 1 e/ Ar: þ N2 (4)
Surfaceþ Ar:/Surface Ar (5)
2.3. In vitro investigations
All FBRR-modified CPEs were cycled in N2 (BOC Ireland) satu-
rated PBS over the potential ranges 0.7 V to þ0.8 V, vs. SCE at
100mV/s. According to Scheme 1, the redox activity of the depos-
ited diazonium salt involves a 2e oxidation, converting the
methoxy to the equivalent quinone, followed by a 2e/2Hþ ex-
change to form the hydroxy-quinone. The potential at which the
redox reactions take place are pH dependent resulting from the
protonation/deprotonation of the quinone [26].
For calibrations performed during Sections 3.3 to 3.7; once
cycling at one pH was complete (50 cycles), the electrodes were
removed from one PBS solution, rinsed in deionised water and
placed in another. The cycling order in the respective pH solutions
was randomised between electrodes. A saturated calomel electrode
(SCE) was used as the reference electrode, unless stated otherwise,
and a large Pt wire served as the auxiliary electrode. Senso-
compatability investigations were performed on separate sets of
FBRR-modified CPEs (n ¼ 4) that were either stored for 24 h or
continuously cycled for 400 and 1100 cycles, in 1% solutions of BSA
and PEA over the potential range0.7 V toþ0.8 V. The effect on the
quinone peak resolution and stability was investigated and
compared for both conditions.
Interference investigations were performed by cycling FBRR-
modified CPEs in PBS containing a physiologically relevant con-
centration of the respective interferents; ascorbic acid (500 mM), L-
cysteine (100 mM), L-glutathione (100 mM), L-Tyrosine (200 mM),
uric acid (100 mM), acetaminophen (500 mM) and acetylsalicylic
acid (500 mM). The effect of the interferent on the quinone peakScheme 1. Redox activity of electrodepositedresolution was elucidated.
I ¼ 0:5
X
z2ici (6)
The ionic strength of the solutions was calculated using Equa-
tion (6), where z is the charge and c represents the concentration of
the ions. Using this Equation, the ionic strength of the PBS was
altered to give ionic strengths of 0.46M, 0.92M and 0.23M and the
sensitivities compared. Selectivity investigations were performed
by cycling FBRR-modified CPEs over various pH, in the presence of
excess concentrations of Ca2þ (1.6mM) and Mg2þ (21mM). The
sensitivities were compared against those obtained in standard PBS
solution without the cations present.
Temperature investigations involved increasing the tempera-
ture of the PBS solution to 37 C using a digital water bath and the
sensitivity was determined and compared against that obtained at
25 C. Finally, the effect of incorporating a PRE into the design was
elucidated. Ag/AgCl-PREs were constructed from Teflon®-insulated
Agwire using a previously described protocol [33]. A 5mm cylinder
was prepared by removing the Teflon® from one end of the elec-
trode. The 5mm Ag cylinder (anode) and a corresponding Pt or Ag
wire (cathode) were immersed in 1.0M HCl for 30 s which resulted
in the formation of a Ag/AgCl layer. The sensitivities were compared
against those obtained using a conventional SCE.
2.4. In vivo surgical protocol
Male Wistar rats (Charles River, UK, 400e600 g) were housed
with a maximum of three per cage in a temperature (17e23 C),
humidity, and light controlled (12 h light, 12 h dark cycle) envi-
ronment at Maynooth University. Food and water were available ad
libitum. The subjects were allowed to acclimatise for at least one
week prior to surgery. The rats were anesthetised with Isoflurane
anaesthesia (Abbott Laboratories, Dublin, Ireland) in the supine
position with the anaesthesia mask fixed tightly around the nose.
The subject was kept on a heating pad for the duration of the
recording to prevent hypothermia. An 18-gauge needle (inner
diameter¼ 0.84mm) which contained the FBRR-modified CPE,quinone group on FBRR-modified CPE.
K.M. Herdman et al. / Electrochimica Acta 298 (2019) 484e495 487auxiliary electrode and Ag/AgCl-PRE, was inserted into the hind-
limb to a depth of ca. 1 cm (see Fig. 1). Once implanted, the hypo-
dermic needle was retracted from the tissue leaving the electrodes
in place. All recordings were carried out with the subjects under
general anaesthesia. Subjects were euthanised upon completion of
recordings by intraperitoneal injection of Euthatal. All experi-
mental procedures were approved by Maynooth University Ethics
Committee and performed under license in accordance with the
European Communities Regulations 2002 (Irish Statutory Instru-
ment 165/2013).2.5. In vivo voltammetric investigations
All electrodes were connected via gold electrical contacts to the
data acquisition equipment. Cycling of the FBRR-modified CPE, over
the potential range 0.7 V to þ0.8 V vs. Ag/AgCl at 100mV/s, was
carried out over a 45-min period (90 cycles) to establish a baseline
peak potential prior to the perturbation. The mean quinone peak
potential was plotted against time for the analysis provided in
Fig. 7. During ischaemia investigations (represented by shaded area
in Fig. 7A), a tourniquet was placed around the subject's limb in
close proximity to the body to facilitate occlusion of the blood
supply as described previously [28]. Ischaemia was induced by
pulling the tourniquet as tight as possible, verified visually by the
increasing pallor of the subject's foot, and was maintained for a 10-
min period. Once completed, the tourniquet was removed and re-
cordings continued for a further 45min (90 cycles). Similarly,
during sodium bicarbonate investigations, cycling of the FBRR-
modified CPE was carried out over a 45-min period (90 cycles) to
facilitate baseline recordings. Subsequently, 100 mL volumes of
45mM sodium bicarbonate were injected directly into the tissue
containing the electrodes after 55, 60 and 65min (represented by
shaded areas in Fig. 7B). Cycling continued for a further 45min (90
cycles). In total, each recording was performed for 100min. Upon
completion of the recordings, the FBRR-modified CPEs were
removed from the hind limb and rinsed with deionised water. They
were then recalibrated as described in Section 2.3 and theFig. 1. Graphic illustration of in vivo recording set-up in the hind limb of anaesthetised ra
hemi zinc chloride (FBRR) on carbon paste electrode (CPE).sensitivities compared against the pre-implantation values.2.6. Instrumentation, software and data analysis
Voltammetric experiments were performed in vitro using a low-
noise potentiostat (ACM Instruments, Cumbria, UK) and converted
using an A/D converter (PowerLab, ADInstruments, Oxford, UK).
In vivo recordings were performed using a Quadstat (eDAQ Ltd.,
Sydney, Australia) and converted using an A/D converter (eCorder,
eDAQ Ltd.). The CV signals were recorded using eChem software
(v2.1.16, eDAQ Ltd., Sydney, Australia) running on a Dell laptop. All
in vitro pH sensitivities were calculated using linear regressions. For
in vivo analyses, the mean quinone peak potential was plotted
against time for the analysis provided in Fig. 7. The number of
electrodes used is denoted by n except for in vivo investigations
whereby n denotes the number of animals. Significant differences
were calculated using the Student's t-test and one-way ANOVAs
followed by Bonferroni post hoc test were performed where
appropriate. The standard 95% confidence interval was used for
these tests, so a p-value less than 0.05 indicated a significant dif-
ference between the data sets, whereas a p-value higher than 0.05
indicated no significant difference. These analyses were performed
using GraphPad Prism® version 5.01 (GraphPad Software Inc., San
Diego, CA, USA). Scanning Electron Microscopy (SEM) analysis was
carried out using a Hitachi S-3200-N, with a tungsten filament
electron gun that has a maximum magnification of 200,000x and
resolution of 3.5 nm. A 5mm long section was cut from the active
end of the CPE. The Teflon® was carefully removed from the bottom
2mm, and the exposed silver wire was angled to 90 and placed
onto 12mm carbon adhesive tabs (Agar Scientific), mounted on
15mm 6mm specimen stubs (Agar Scientific), so that the
modified surfacewas ca. 90 to themount. The stubs were placed in
the sputter coater and a vacuum was applied for 30min. Sputter
coating was performed, under argon, with an Au/Pd target, until a
thickness of 5 nm was obtained.ts and electrodeposited 4-benzoylamino-2, 5-dimethoxybenzenediazonium chloride -
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3.1. Sensocompatability investigations
FBRR-modified CPEs were exposed to aqueous solutions of the
protein, BSA and the lipid, PEA, to determine the effect on the
anodic peak stability and resolution. Both have been utilised pre-
viously to characterise the response of electrochemical sensors to
in vivo conditions [25,34e37]. The material-tissue interaction that
results from sensor implantation is one of the major obstacles in
developing viable, long term implantable sensors. The effect of
storing FBRR modified CPEs for 24-h in 1% BSA solution is detailed
in Supplementary Fig. SM1A. It is apparent that the anodic peaks
are retained, however, the peak resolution has been greatly
compromised and the peak potential shifted slightly. This can be
attributed to the adsorption of proteinmolecules onto the electrode
surface. The tendency is to build up a layer, inhibiting electron-
transfer processes and resulting in an altered voltammogram
[38]. This finding was not entirely unexpected. To determine the
impact of applying a constant potential profile to the electrode
surface in the BSA solution, the FBRR-modified CPEs were contin-
uously cycled in the 1% BSA solution for 3.5 h (see Fig. 2A) and 9 h
(see Fig. 2B). There is a huge improvement in the peak resolution in
contrast to FBRR-modified CPEs stored in 1% BSA for 3.5 h (see
Fig. SM1B). It is apparent that the constant application of anFig. 2. Effect of continuous cycling on FBRR-modified carbon paste electrodes (CPE) anodic p
in 1% phosphatidylethanolamine (PEA) for (C) 400 cycles, (D) 1100 cycles. FBRR-modified CP
100mV/s (n¼ 4). Voltammograms performed at each 50th cycle included in A/C and each 1oxidation potential followed by a reduction potential prevents the
protein layer from building up on the surface. A plausible expla-
nation for this is detailed in Fig. SM1C. Increasing peak currents
were observed during continuous cycling of the modified CPE in
PBS which can be attributed to the gradual loss of silicon oil from
the carbon paste. This loss of oil could prevent the build-up of large
deposits of BSA on the surface. Furthermore, trace amounts of BSA
remaining on the electrode surface may in fact enhance electron
transfer [39] resulting in improved peak resolution and definition.
In contrast the broader peaks with reduced definition present in
Fig. SM1A and B are indicative of a decrease in electron transfer. The
continuous cycling would be more representative of the targeted
application in peripheral muscle monitoring supporting the sta-
bility of the pH sensitive moiety on the CPE surface.
The effect of storing the CPEs in 1% PEA for 24 h is illustrated in
Fig. SM1D. As described earlier, a broad, ill-defined anodic peak was
recorded post-storage which was to be expected, due to the well-
established ability of lipids to remove the hydrophobic elements
from the electrode surface, producing a more carbon powder like
morphology [25]. Notwithstanding this, the effect of continuous
cycling in PEA solution identified an improvement in peak intensity
and resolution over 3.5 h (see Figure 2C) and 9 h (see Fig. 2D), albeit
with slight shifts observed in the latter over the course of the
cycling. These findings suggest that the PEA had not fouled the
surface. Moreover, it suggests that it had enhanced the electroneak potentials in 1% bovine serum albumin (BSA) for (A) 400 cycles, (B) 1100 cycles and
Es cycled over potential range e 0.7 V to þ0.8 V vs. saturated calomel electrode (SCE) at
00th cycle in B/D.
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the electrodes were stored in lipid for 3.5 h as highlighted in
Fig. SM1E. The application of the constant potential profile facili-
tated the adsorption and desorption of trace amounts of PEA on the
CPE surface, preventing the build-up of the lipid layer. Collectively,
these findings support the ability of the FBRR-modified CPE to
perform stable measurements under physiological conditions, for a
minimum of 9 h, through application of a constant potential profile.3.2. Interference investigations
The FBRR-modified CPEs were cycled in PBS containing physi-
ologically relevant concentrations of interferents present in pe-
ripheral interstitial fluid. The principal objective of this interference
study was to confirm retention of the pH sensitive quinone peak in
the presence of endogenous interferents. Table 1 details the find-
ings from these investigations and Fig. 3 and SM2 illustrate the
voltammograms recorded for each. There was a potential change
recorded in the presence of certain interferents which was attrib-
uted to a shift in the pH of the solution. Examples of this are
illustrated in Fig. 3. The voltammetric profile was repeated with the
pH adjusted back to 7.4 and statistical analysis performed on the
potential difference recorded for the quinone peak in the presence
and absence of the interferent. In summary, there was no signifi-
cant difference (p> 0.05) observed in quinone peak potential, in the
presence of a physiological concentration of the endogenous spe-
cies; ascorbic acid, uric acid, L-cysteine, L-tyrosine or L-gluthathione.
Furthermore, two of the most commonly prescribed medications in
clinical practice; acetaminophen and acetylsalicylic acid, had no
significant effect (p> 0.05) on the pH sensitive peak potential, at
clinically relevant concentrations. Moreover, the change in pH
observed in the presence of the interferents validated the ability of
the quinone peak to shift potential in the presence of the inter-
ferent. In addition, voltammetric data obtained over an extended
calibration range (pH 6.0e8.0, see Fig. 4A) supports our assumption
further. The largest anodic potential recorded was <þ100mV at pH
6.0. It is obvious from Fig. 3 and SM2 that there will be no contri-
bution from any interfering agent at this potential, supporting
retention of the quinone peak at this pH value. This can be best
described by Fig. SM3A and B whereby clear and resolved redox
peaks attributed to uric acid and acetaminophen, respectively, are
clearly visible. However, there is no impact on the quinone oxida-
tion peak due to the larger anodic potentials recorded for the
interferents. In addition, the sensitivity of the FBRR-modified CPE,
calculated for the pH range 6.0e8.0, was 58± 2mV/pH (n¼ 5,
r2> 0.99). This value is not significantly different (p¼ 0.90) than the
sensitivity calculated over the pH range 7.2e7.6 (59± 3mV/pH,
n¼ 37, r2> 0.99) which we reported previously [26]. This finding
reinforces the ability of the FBRR-modified CPE to function over a
larger pH range, however, to focus more closely on basal pH re-
cordings, all further characterisation data was performed over theTable 1
Effect of physiological interferents (Int) on FBRR-modified CPEs anodic peak potentials (n
(Int, pH adjusted) e Ep (PBS). p-value calculated from Ep (Int, pH adjusted) vs. Ep (PBS).
Interferent (Int) DEp, mV Ep (Int) e Ep (PBS)
Ascorbic acid 4± 6 pH 7.31
Uric acid n/a
L-Cysteine 9± 3 pH 7.34
L-Tyrosine 2± 2 pH 7.38
L-Glutathione 3± 2 pH 7.36
Acetaminophen 6± 2 pH 7.34
Acetylsalicylic acid 1± 3 pH 7.34shorter pH range of 7.2e7.6.
Despite peripheral monitoring being the core application of this
design, Table SM1 and Fig. SM3 highlight the selectivity charac-
teristics of the FBBR-modified CPE against known interferents in
the brain extracellular fluid for a broader range of applications.
There was no significant difference (p> 0.05) recorded in the
anodic peak potential when cycled in the presence of dopamine,
DOPAC and 5-Hydroxy-Indole Acetic Acid.3.3. Ionic strength investigations
The effect of ionic strength on the FBRR functionalised elec-
trodes was tested by cycling the modified electrodes in PBS of
altered ionic strength over the chosen pH range. Many pH sensors,
in particular those pertaining to optical measurements, have a basic
disadvantage of measuring signals that depend on the ionic
strength of the sample [40]. It is obvious from Fig. 4B that excellent
linearity was observed across all ionic strengths (r2> 0.99). There
was no significant difference (p¼ 0.18, one-way ANOVA) observed
across the sensitivities recorded in 0.23M (60± 1mV/pH, n¼ 4),
0.46M (54± 3mV/pH, n¼ 4) or 0.92M (58 ± 1mV/pH, n¼ 3).
Furthermore, Bonferroni post hoc analysis identified no significant
variation between the respective ionic strengths. These findings
confirm that increasing and decreasing the solution conductivity
failed to cause a significant variation in the sensor performance
across the varying pH range.3.4. Cation selectivity investigations
It was imperative to investigate the selectivity of the quinone
anodic peak for Hþ ions in solution. This was confirmed by intro-
ducing increased concentrations of Mg2þ and Ca2þwhich are two of
the most prevalent cations found in biological systems with
average concentrations of 5mM [41,42] and 1.2mM [43], respec-
tively. They are also known to form coordinate bonds and com-
plexes with several quinones [44,45] and could therefore affect
their redox peak potentials. Fig. 5A and B detail the effect of
increasing Mg2þ and Ca2þ concentrations respectively, with excel-
lent linear responses observed across all concentrations. Initial
calibration of the FBRR-modified CPEs resulted in a sensitivity value
of (54± 2mV/pH, n¼ 4). No significant differencewas recorded in
increased [Mg2þ] (55± 4mV/pH, n¼ 4, p¼ 0.78) and [Ca2þ]
(56 ± 2mV/pH, n¼ 4, p¼ 0.49) in PBS, confirming the selectivity
of the quinone anodic peak for Hþ over these cations. This excellent
selectivity for Hþ ions is in close agreement with work described
previously byMakos et al. using FBRR on carbon fibre electrodes [2].
This suggests a higher affinity of the quinone group for protons over
the respective cations in solution. This is to be expected since
quinone groups are well-established as being pH dependent and
have been developed for the determination of pH [15,16,46].¼ 4). Data presented as DEp whereby DEp¼ Ep (Int) e Ep (PBS) and DEpadjusted¼ Ep
DEpadjusted, mV Ep (Int, pH adjusted) - Ep (PBS) p-value
1 ± 6 pH 7.40 0.86
0 ± 4 pH 7.40 0.92
5± 3 pH 7.40 0.10
1± 2 pH 7.40 0.73
1± 2 pH 7.40 0.96
2± 2 pH 7.40 0.31
1 ± 2 pH 7.40 0.52
Fig. 3. Voltammograms recorded using FBBR-modified CPEs in the presence of physiological concentrations of electroactive interferents (A) 500 mM ascorbic acid (CPE/FBRR-AA) (B)
100 mM L-cysteine (CPE/FBRR-L-Cys) (C) 100 mM L-gluthathione (CPE/FBRR-L-Glut) and (D) 200 mM L-tyrosine (CPE/FBRR-L-Tyr). CPEs cycled over potential range e 0.7 V to þ0.8 V vs.
SCE at 100 mV/s (n¼ 4). Cycle 100 included for each CV.
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Heretofore, all previous experiments were carried out at room
temperature, i.e. 22 C. Since the principal objective of this work
was to perform physiological monitoring, i.e. at 37 C, it was critical
to determine the effect of increasing temperature on the pH sen-
sor's performance. The anodic peaks in Fig. 6A illustrate the cor-
responding potentials when cycling in PBS of varying pH. The first
difference observed was the increased currents obtained with
increased temperature due to an increase in the rate of the redox
reaction. The second was the shift to a more negative potential for
the values obtained at the higher temperature. This is because pH
changes with temperature, according to the Rosenthal Correction
Factor, by 0.015 pH units per C [47]. This results in a shift of 0.225
pH units for the temperature difference of 15 C. Assuming a
Nernstian response of 59mV/pH then the expected shift in peak
potential is 13mV. Therefore, if the peak potential at 22 C
is 34mV, the expected peak potential at 37 C would be 47mV.
Comparing the peak potentials at similar pH values between 22 C
and 37 C in Fig. 6A gave potential shifts of approximately 20mV
(see Table SM2). Furthermore, the pH response is dependent on
temperature according to:
m ¼ 2:303RT=F (6)
Where m is the slope or pH response, R is the universal gas
constant (J K1 mol1), T represents the temperature (K) and F
denotes the Faraday constant (C mol1). This results in a pH
response of 62mV/pH at a temperature of 37 C. The pH re-
sponses at both temperatures are shown in Fig. 6A inset. They
demonstrate excellent pH sensitivities with slopes of 59± 2
and 63 ± 1mV/pH for 22 C and 37 C, respectively, with r2values> 0.99. This is in close agreement with the theoretical value
of 62mV/pH unit obtained from the Nernst equation for a 2
electron, 2 proton transfer at 37 C. These sensitivities highlight the
temperature dependence of the Nernst equation [48] and further
demonstrate the efficacy of the developed sensor at measuring
reliable pH shifts.3.6. Ag/AgCl-PRE
To facilitate in vivo recordings, the SCE is normally replaced by a
miniaturised PRE. It is extremely difficult to determine the precise
potential of a PRE [49] which may compromise its utility in vol-
tammetric measurements. Notwithstanding this, PREs have been
extensively utilised for in vivo recordings in freely moving [33] and
anaesthetised rodents [28]. Furthermore, it has been reported that
PREs in PBS pH 7 maintain a constant potential [50], making them
suitable for use in areas where the pH is regulated, e.g., biological
systems. Therefore, it was vital to investigate the effect of changing
reference electrodes on the quinone anodic peak potential. The
anodic peaks from the resulting CVs are highlighted in Fig. 6B and
clearly identify a shift in potential caused by using the Ag/AgCl-PRE,
of approximately 34mV, compared to the SCE. Literature values
for the potential difference between Ag/AgCl and SCE reference
electrodes suggest a shift of 44mV [51]. There is also a clear shift
in quinone peak potentials when changing the solution pH with
linear regression analysis provided in Fig. 6B inset. There was no
significant difference (p¼ 0.47) recorded between sensitivities
recorded for the SCE (57± 1mV/pH, n¼ 4) and Ag/AgCl-PRE
(56 ± 1mV/pH, n¼ 4). Despite obvious discrepancies in peak
potentials between the two reference electrode systems, the
extremely comparable sensitivities negate this issue. However, it is
Fig. 4. (A) Comparison of pH sensitive quinone peaks of FBRR-modified CPEs (n ¼ 5)
cycled in PBS of pH 6.0 (black), pH 6.5 (red), pH 7.0 (green), pH 7.5 (blue) and pH 8.0
(purple). CPEs cycled over potential range 0.7 V to þ0.8 V vs. SCE at 100mV/s. Cycle
50 included for each pH. Inset: Corresponding potential-pH profile and linear regres-
sion analysis for oxidation peak potentials. (B) Potential-pH profiles and linear
regression analysis comparing pH responses of FBRR-modified CPEs in solutions of
varying ionic strength; 0.23M (green), 0.46M (red) and 0.92M (blue). (For interpre-
tation of the references to colour in this figure legend, the reader is referred to the Web
version of this article.)
Fig. 5. Comparison of pH sensitive quinone peaks of FBRR-modified CPEs (n¼ 4)
cycled in PBS of pH 7.2 (blue), 7.4 (red) and 7.6 (green) in the presence of (solid lines,
right y-axes) and absence of (dashed lines, left y-axes) (A) 21mMMg2þ and (B) 1.6mM
Ca2þ. CPEs cycled over potential range 0.7 V to þ0.8 V vs. SCE at 100mV/s. Vol-
tammograms performed at each 50th cycle included. Insets: corresponding potential-
pH profiles and linear regression analysis (n¼ 4) performed in PBS with increase
cation concentration (blue) and without (red). (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this article.)
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elucidated prior to deployment of this system in physiological
media.3.7. In vivo measurements in the hind limb of anaesthetised rats
Acute in vivo investigations were undertaken in the peripheral
muscle of anaesthetised rats to confirm the efficacy of the FBRR-
modified CPE at monitoring pH changes under physiological con-
ditions. The CPEs were modified as described and implanted in
combinationwith a Ag/AgCl-PRE and auxiliary electrode, through a
hypodermic needle, into the hind limb of the anaesthetised subject.
The CPE was cycled between 0.7 V and þ0.8 V vs. Ag/AgCl at
100mV/s. An initial baseline recording was performed over 90
cycles (45min) to obtain a stable quinone peak potential and this isdetailed in Fig. SM4B. Using the dashed line as a point of reference,
it is clear that the stability of the peak is retained over the 90 cycles.
Moreover, the 90th cycle, recorded at the end of the settling phase,
had its peak potential located at ca. 82mV vs. Ag/AgCl which
equates to a pH of 7.60 using the potential responses described for
Ag/AgCl-PRE in the previous section and detailed in Table SM2.
However, it is important to emphasise that these potentials were
obtained at 22 C and it is imperative that we incorporate the effect
of increased temperature when determining the baseline pH levels,
i.e. 20mV shift between 22 C and 37 C. This postulates a po-
tential of 62mV at 22 C which is closer to a baseline pH level of
7.25. This is in close alignment to in vivo baseline levels recorded
Fig. 6. Comparison of pH sensitive quinone peaks of FBRR-modified CPEs cycled in PBS
of pH 7.2 (blue), 7.4 (red) and 7.6 (green) recorded (A) at 22 C (dashed line, left y-axis)
and 37 C (solid line, right y-axis) and (B) using a Ag/AgCl-pseudo reference electrode
(PRE) (solid lines, right y-axis) and a SCE (dashed lines, left y-axis). CPEs cycled over
potential range 0.7 V to þ0.8 V vs. SCE at 100mV/s. Voltammograms performed at
each 50th cycle included. Insets: corresponding potential-pH profiles and linear
regression analysis (n¼ 4) performed at 22 C (blue)/37 C (red) and using Ag/AgCl PRE
(blue)/SCE (red). (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)
Fig. 7. In vivo recordings performed using FBRR-modified CPEs in the hind-limb of
anaesthetised wistar rats over the potential range e 0.7 V to þ0.8 V vs. Ag/AgCl at
100mV/s. Average potential-time profiles from FBRR-modified CPEs in (A) hind-limb
model of ischaemia to lower tissue pH (n¼ 4) and (B) injection of sodium bicarbon-
ate to increase tissue pH (n¼ 4). Insets: close-up of shaded areas representative of
perturbation. Red arrows indicate start/end of ischaemic insult (A) and various in-
jections of sodium bicarbonate (B). (For interpretation of the references to colour in
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[18,19,33].
Two perturbations were performed in separate animal cohorts
to determine the efficacy of the FBRR-modified CPE at monitoring
shifts in muscle pH. Localised changes in pH were brought about by
the induction of ischaemia to reduce the pH or by the injection of
bicarbonate ions to increase pH. After a short recording time period,
the tissue pH was allowed to recover. Reduced blood flow results in
tissue ischaemia, causing insufficient oxygen and nutritional re-
quirements, starving the affected tissue of its metabolic needs. The
reduced oxygen supply to the tissue causes cell metabolism to
change from aerobic to anaerobic which results in the production of
lactic acid. This, along with increased levels of CO2, induces adecrease in pH levels [52]. A tourniquet was applied to the hind
limb to induce ischaemia using a model previously described [28].
Fig. 7A and SM4A illustrate the quinone peak potential shift over
the duration of the 200 cycles (100min). The inset in Fig. 7A
highlights the shaded area and red arrows indicate the application
of ischaemic insult. There was an obvious increase in quinone peak
potential observed, from a pre-insult level of 52mV, to a
maximum response of 17mV vs. Ag/AgCl, over the course of the
tourniquet application. This group of FBRR-modified CPEs had an
in vitro pH sensitivity of 57± 2mV/pH (n¼ 4), corresponding to a
shift of 0.65 pH units resulting from the ischemic episode. This
decrease is consistent with literature values reporting a pH drop of
0.70 pH units after 60min [53]. During ischaemia, tissue pH can
drop to as low as 6.0e6.5 in-vivo [54]. It is detailed in Fig. 4A that
linearity is retained at these lower pH values, supporting the ac-
curacy of our sensor data. Post-ischemic insult, the tissue was
shown to rapidly return and slightly overshoot the pre-insult
baseline, a potential shift from 17mV to 55mV vs. Ag/AgCl,
indicating tissue reperfusion. This corroborates findings using a
tissue oxygen sensor in the same animal model, whereby a rapidthis figure legend, the reader is referred to the Web version of this article.)
Fig. 8. (A) Comparison of pH sensitive quinone peaks of FBRR-modified CPEs (n¼ 4) cycled in PBS of pH 7.2 (blue), 7.4 (red) and 7.6 (green) recorded pre-implantation (solid line,
right y-axis) and post implantation (dashed lines, left y-axis) in vivo. CPEs cycled over potential range 0.7 V to þ0.8 V vs. SCE at 100mV/s. Voltammograms performed at each 50th
cycle included. Inset: corresponding potential-pH profiles and linear regression analysis (n¼ 4) for pre-implanted (blue trace) and post implanted (red trace) FBRR-modified CPEs.
(B) SEM images illustrating pre-implanted (left) and post-implanted (centre, right) FMRR-modified CPEs. (For interpretation of the references to colour in this figure legend, the
reader is referred to the Web version of this article.)
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crease in pH can be explained by reperfusion following restoration
of vasculature supply and aerobic metabolism. This finding strongly
supports the efficacy of the FBRR-modified CPE at measuring a
decrease in physiological pH.
To induce an increase in pH levels, injections of sodium bicar-
bonate [30e32], a weak base, were administered locally to the hind
limb of the animals. Bicarbonate therapy is a known treatment
administered to patients suffering from the effects of acidosis [32].
Fig. 7B and SM4C highlight the quinone peak potential shift over
the duration of the 200 cycles (100min). The inset highlights the
shaded area and red arrows indicate the injections of 45mM so-
dium bicarbonate. It was apparent that, immediately after the 1st
and 2nd injections, there was an unexpected increase in the peak
potential, which was interpreted as injection stress. However, a
large drop in quinone peak potential was recorded over the course
of the 2nd and 3rd injections with a maximum potential
of 110mV recorded. This maximum drop in peak potential cor-
responded to a pH rise of 0.61 pH units (n¼ 4), indicating severe
alkalemia [55] or alkalosis. The peak potential returned to a pre-
injection level of 88mV after 65min (20-min post-injection)
illustrating the ability of the physiological tissue to correct the pH
shift in a timely manner. Once again, these findings strongly sup-
port the efficacy of the FBRR-modified CPE at measuring a deviation
in physiological pH and demonstrates its in vivo utility.
Finally, post in vivo calibrations were performed on the
implanted FBRR-modified CPEs. The average sensitivity recorded
was 60± 1mV/pH (n¼ 4, r2> 0.99) which was not significantlydifferent than the pre-implantation sensitivity (57± 2mV/pH,
n¼ 4, r2> 0.99). However, it is obvious from Fig. 8A that the reso-
lution of the quinone peak has been compromised with a
concomitant shift in the peak potential observed. This supports our
sensocompatability findings; in particular Fig. SM1, where a
broadening of the quinone peak, after 24 h storage in proteins and
lipids was recorded, along with a shift in the peak potential also.
The SEM images in Fig. 8B illustrate discrepancies in the surface
morphology of the pre-implanted and post-implanted CPEs which
is not entirely unexpected. The smooth surface of the CPE in the left
image is replaced by an uneven, concave shaped surface in the
centre and right sided image. The altered surface is more than likely
caused by a combination of proteins and lipids coupled with
physical damage caused by the removal process which could give
rise to the broader peaks observed in Fig. 8A. Notwithstanding this,
improved peak resolution was observed for sensocompatability
studies performed during continuous cycling in proteins and lipids
and more importantly during in vivo recordings (see Fig. SM4B).
Collectively, these findings support the functionality of the FBRR-
modified CPE during in vivo recordings and demonstrate reten-
tion of the electrodeposited diazonium salt on the CPE surface
following exposure to physiological conditions.
4. Conclusion
We have presented the in vitro characterisation and in vivo
validation of a FBRR-modified CPE for the physiological monitoring
of pH. An in-depth characterisation supported the ability of the
K.M. Herdman et al. / Electrochimica Acta 298 (2019) 484e495494modified electrode to perform stable measurements during
continuous cycling in solutions of protein and lipid, for a minimum
of 9 h. Furthermore, peak resolution and stability were retained in
the presence of an abundance of physiological interferents identi-
fied from both peripheral and brain extracellular fluid. There was
no effect on sensor performance due to variations in ionic strength
and cation concentrations. In addition, the influence of tempera-
ture and reference electrodes were elucidated to facilitate accurate
pH monitoring under physiological conditions. Finally, the FBRR-
modified CPE demonstrated the ability to monitor pH changes in
the muscle tissue of anaesthetised rats exposed to ischaemia and
injections of sodium bicarbonate. Post-implantation calibrations
demonstrated no significant difference in sensitivity when
compared against pre-implanted values. The work described
strongly supports the ability of the FBRR-modified CPE to measure
accurate changes in peripheral tissue pH. Furthermore, the work
supports its deployment in brain applications also.
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